Form D — GPN VACCINES, INC.
0002105609-26-000001 · filed Jan 28, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $10,000,000
- Reported amount sold
- $3,500,000
- Minimum investment
- $228
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- GPN VACCINES, INC.
- CIK
- 2105609
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808 - Phone
- 61 420 942 8224
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Timothy Hirst · Executive OfficerNew York, NY Find on LinkedIn ↗
-
James Selkirk · Executive OfficerNew York, NY Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗